C. Renner

Maya Healers' Conception of Cancer as Revealed by Comparison With Western Medicine

Christoph Renner, Eduardo Gharzouzi, M. Berger-González, 2016, Journal of global oncology.

Use of inpatient rehabilitation for cancer patients in Switzerland: who undergoes cancer rehabilitation?

B. Fuchs, U. Schnyder, J. Jenewein, 2015, Swiss medical weekly.

Short-term effectiveness of inpatient cancer rehabilitation: A longitudinal controlled cohort study

U. Schnyder, J. Jenewein, J. Barth, 2017, Journal of Cancer.

Alternate-day dosing of pomalidomide in relapsed/ refractory multiple myeloma: a multicenter, single-arm phase 2 trial

S. Aebi, T. Pabst, S. Schär, 2023, Leukemia.

Outcome and Prognostic Factors of COVID-19 Infection in Swiss Cancer Patients: Final Results of SAKK 80/20 (CaSA)

K. Zaman, A. Stathis, O. Michielin, 2022, Cancers.

Integrating novel agents into multiple myeloma treatment - current status in Switzerland and treatment recommendations.

M. Gregor, D. Betticher, T. Pabst, 2010, Swiss medical weekly.

Cost-effective therapy remission assessment in lymphoma patients using 2-[fluorine-18]fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography: is an end of treatment exam necessary in all patients?

P. Veit-Haibach, T. Hany, N. Schaefer, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma

M. Ghielmini, P. Zinzani, G. Martinelli, 2012, Haematologica.